Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Amanda Clancy"'
Autor:
Conor J. Gallagher, Ronald R. Bowsher, Amanda Clancy, Jeffrey S. Dover, Shannon Humphrey, Yan Liu, Gregg Prawdzik
Publikováno v:
Toxins, Vol 15, Iss 1, p 60 (2023)
DaxibotulinumtoxinA for Injection (DAXI) is a novel botulinum toxin type A product containing daxibotulinumtoxinA with a stabilizing excipient peptide (RTP004). DAXI immunogenicity was assessed in three phase 3 glabellar line studies (two placebo-con
Externí odkaz:
https://doaj.org/article/e0722c1b95914de6967e1bb40c7a805f
Autor:
Shannon Humphrey, Jeffrey S Dover, Ronald R Bowsher, Amanda Clancy, Yan Liu, Gregg Prawdzik, Conor J Gallagher
Publikováno v:
Aesthetic Surgery Journal.
DaxibotulinumtoxinA-lanm for injection (DAXI), a novel botulinum toxin type A formulation, contains a purified 150-kD core neurotoxin (daxibotulinumtoxinA) and proprietary stabilizing peptide (RTP004), and is approved for glabellar line treatment. As
Autor:
Shannon Humphrey, Jeffrey S. Dover, Ronald R. Bowsher, Amanda Clancy, Yan Liu, Conor J. Gallagher
Publikováno v:
Toxicon. 214:S25-S26
Autor:
Mingxuan Zhang, Wei Guo, Ellie Im, Ronald R. Bowsher, Sharon Lu, Ashley Milton, Minggeng Gao, Elizabeth Potocka, Kathleen Koeck, Ying Yang, Amanda Clancy, Amy Rosen, Kai Yu Jen
Publikováno v:
The AAPS Journal
Monoclonal antibodies that block the interaction between programmed cell death 1 (PD-1) and its ligand (PD-L1) have revolutionized cancer immunotherapy. However, immunogenic responses to these new therapies—such as the development of antidrug antib